Partnerships - Pharmaceutical Executive



Copay Cards and Coupons: Letting the Facts Get in the Way

January 1, 2012

Mason Tenaglia offers empirical defense of coupons and copay offset programs.

Pharm Exec's 2012 Pipeline Report

December 1, 2011

It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?

The Power of Product Development Partnership

September 1, 2011

Can cooperative ties between Big Pharma, NGOs, government, and international organizations pay the freight in making the fight against neglected diseases a permanent fix in global health?

The Adherence Fight: A TKO?

August 1, 2011

Why does the match against medicines compliance always seem to end in an easy knockout?

Optimizing your Value with Payers

June 1, 2011

Successful negotiations require a willingness to take risks and an ability to adapt

High-Risks to High Reward

May 1, 2011

According to Eli Lilly, managing alliances requires more than good people skills

Bridging the HCP-Patient Gap

April 1, 2011

Pfizer's Sarah Krug describes what's necessary to bridge the gap between the patient revolution and healthcare provider in the 21st century

Washington Report: New Partnerships Pursue Old Diseases

September 1, 2006

The PPP approach asks pharma to identify promising drugs and conduct pre-clinical tests, instead of paying for costly late-stage clinical trials.


Click here